sesamol has been researched along with Body Weight in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 3 (27.27) | 2.80 |
Authors | Studies |
---|---|
Hu, M; Li, S; Qin, H; Shaukat, H; Song, Z; Zheng, W | 1 |
Guo, R; Jiang, Y; Li, Q; Liu, X; Liu, Z; Wang, X; Wang, Y; Yuan, T; Zhang, Y; Zhao, Y | 1 |
Bhaskaran, NA; Gourishetti, K; Jitta, SR; Keni, R; Krishnadas, N; Kumar, L; Kumar, N; Nayak, PG; Shenoy, RR | 1 |
Kumar, N; Kutty, NG; Mudgal, J; Nayak, PG; Parihar, VK; Rao, CM | 1 |
Kondamudi, PK; Kovelamudi, H; Mathew, G; Nayak, PG; Rao, CM; Shenoy, RR | 1 |
Chen, Y; Liu, X; Liu, Z; Qiao, Q; Ren, B; Sun, Y | 1 |
Arya, DS; Bharti, S; Bhatia, J; Kumari, S; Malik, S; Nepal, S; Ray, R; Sharma, AK | 1 |
Chopra, K; Jindal, S; Kaur, A; Kaur, IP | 1 |
Hirose, M; Kato, T; Shirai, T; Takesada, Y; Tamano, S; Tanaka, H | 1 |
Hasegawa, R; Hirose, M; Hoshiya, T; Ito, N; Shirai, T; Takaba, K; Tiwawech, D | 1 |
Asakawa, E; Fukushima, S; Hasegawa, R; Hirose, M; Ito, N; Kato, T; Shirai, T; Tanaka, H | 1 |
11 other study(ies) available for sesamol and Body Weight
Article | Year |
---|---|
Protective Effects of Sesamol against Liver Oxidative Stress and Inflammation in High-Fat Diet-Induced Hepatic Steatosis.
Topics: Animals; Antioxidants; Benzodioxoles; Biomarkers; Body Weight; Diet, High-Fat; Energy Intake; Inflammation; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phenols; Superoxide Dismutase | 2021 |
Sesamol Mitigates Chronic Iron Overload-Induced Cognitive Impairment and Systemic Inflammation via IL-6 and DMT1 Regulation.
Topics: Animals; Benzodioxoles; Body Weight; Cognitive Dysfunction; Inflammation; Interleukin-6; Iron; Iron Overload; Mice | 2023 |
Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats.
Topics: Animals; Benzodioxoles; Blood Glucose; Body Weight; Calorimetry, Differential Scanning; Diabetes Mellitus, Experimental; Diabetic Foot; Diet, High-Fat; Disease Models, Animal; Drug Liberation; Extracellular Signal-Regulated MAP Kinases; Glucose Tolerance Test; HSP27 Heat-Shock Proteins; Male; Nanoparticles; Neovascularization, Physiologic; Phenols; Platelet-Derived Growth Factor; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Streptozocin; Suspensions; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Wound Healing | 2020 |
Sesamol treatment reduces plasma cholesterol and triacylglycerol levels in mouse models of acute and chronic hyperlipidemia.
Topics: Acute Disease; Animals; Antioxidants; Benzodioxoles; Body Weight; Cholesterol; Chronic Disease; Hyperlipidemias; Hypolipidemic Agents; Male; Mice; Phenols; Sesamum; Triglycerides | 2013 |
Modulatory effects of sesamol in dinitrochlorobenzene-induced inflammatory bowel disorder in albino rats.
Topics: Animals; Antioxidants; Benzodioxoles; Body Weight; Colon; Dinitrochlorobenzene; Granulocyte Colony-Stimulating Factor; Inflammatory Bowel Diseases; Interleukin-3; Interleukin-6; Male; Nitrites; Phenols; Rats; Rats, Wistar; Recombinant Fusion Proteins; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2013 |
Sesamol ameliorates diet-induced obesity in C57BL/6J mice and suppresses adipogenesis in 3T3-L1 cells via regulating mitochondria-lipid metabolism.
Topics: 3T3-L1 Cells; Adipogenesis; Adipose Tissue, White; Animals; Benzodioxoles; Body Weight; Diet, High-Fat; Gene Expression Regulation; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondria, Liver; Obesity; Phenols | 2017 |
Sesamol alleviates diet-induced cardiometabolic syndrome in rats via up-regulating PPARĪ³, PPARĪ± and e-NOS.
Topics: Animals; Antioxidants; Benzodioxoles; Body Weight; Cardiovascular Diseases; Cholesterol; Diet, High-Fat; Dose-Response Relationship, Drug; Dyslipidemias; Fatty Liver; Hepatocytes; Hyperglycemia; Hypertension; Insulin Resistance; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Obesity; Phenols; PPAR alpha; PPAR gamma; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Up-Regulation | 2012 |
Effect of sesamol on the pathophysiological changes induced by surgical menopause in rodents.
Topics: Animals; Antioxidants; Anxiety; Benzodioxoles; Body Weight; Bone Density; Estradiol; Female; Lipid Peroxidation; Lipids; Memory; Menopause, Premature; Models, Animal; Organ Size; Ovariectomy; Oxidative Stress; Phenols; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Uterus | 2013 |
Carcinogenicity of antioxidants BHA, caffeic acid, sesamol, 4-methoxyphenol and catechol at low doses, either alone or in combination, and modulation of their effects in a rat medium-term multi-organ carcinogenesis model.
Topics: Animals; Anisoles; Antioxidants; Benzodioxoles; Body Weight; Butylated Hydroxyanisole; Caffeic Acids; Carcinogens; Catechols; Dose-Response Relationship, Drug; Drug Interactions; Hyperplasia; Kidney; Liver; Male; Neoplasms, Experimental; Organ Size; Phenols; Rats; Rats, Inbred F344; Stomach; Stomach Neoplasms | 1998 |
Suppression of diethylnitrosamine-initiated preneoplastic foci development in the rat liver by combined administration of four antioxidants at low doses.
Topics: Animals; Antioxidants; Benzodioxoles; Body Weight; Bromodeoxyuridine; Butylated Hydroxyanisole; Catechols; Diethylnitrosamine; Dose-Response Relationship, Drug; Drug Synergism; Glutathione Transferase; Hydroquinones; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Phenols; Precancerous Conditions; Rats; Rats, Inbred F344 | 1992 |
Stomach carcinogenicity of caffeic acid, sesamol and catechol in rats and mice.
Topics: Animals; Antioxidants; Benzodioxoles; Body Weight; Caffeic Acids; Carcinogens; Carcinoma, Squamous Cell; Catechols; Cinnamates; Epithelium; Female; Hyperplasia; Male; Mice; Papilloma; Phenols; Rats; Rats, Inbred F344; Sarcoma; Stomach; Stomach Neoplasms | 1990 |